The efficacy of transarterial chemoembolization combined with helical iodine-125 seed implant, lenvatinib and PD-1 inhibitors in patients with hepatocellular carcinoma complicated by main portal vein tumor thrombus: a retrospective study
The integration of the helical I-125 seed implant with TACE, lenvatinib, and PD-1 inhibitors is the safe and efficacious approach in the management of HCC complicated by MPVTT.
Authors
- Wansheng Wang (ORCID: https://orcid.org/0000-0002-2128-7501)
- Jun Yang (ORCID: https://orcid.org/0000-0002-9401-3528)
- Jiawen Lin (ORCID: https://orcid.org/0000-0003-2950-1776)
- Shen Zhang (ORCID: https://orcid.org/0000-0001-5374-1521)
- Yu Yin (ORCID: https://orcid.org/0000-0001-9392-0516)
- Cai‐Fang Ni (ORCID: https://orcid.org/0000-0002-5953-781X)
- Jian Shen (ORCID: https://orcid.org/0000-0003-1877-586X)
Institutions
- Soochow University (CN)
- First Affiliated Hospital of Soochow University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-05-08
- DOI
- https://doi.org/10.3389/fonc.2025.1514375
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Jiangsu Commission of Health